Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement

Launched by UNIVERSITY OF AARHUS · Dec 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special exercise program designed to strengthen the hip compared to regular rehabilitation after hip replacement surgery. Specifically, it looks at patients who are having their first revision hip replacement surgery, which is when a previous hip replacement needs to be fixed or replaced. The goal is to see if this exercise program can help improve physical function, making it easier for patients to move around and do daily activities, compared to the usual care they would receive in the community.

To be eligible for this study, participants need to be at least 18 years old and motivated to join a 16-week exercise program. They should have undergone a specific type of hip surgery where parts of the hip joint (like the cup or stem) were replaced. However, those who use a wheelchair, are planning other leg surgeries soon, have a high body weight, or are currently receiving certain cancer treatments cannot participate. If chosen, participants will engage in the exercise program and will be tested on their physical abilities at the beginning and after 16 weeks to see how much they improve. This trial aims to find better ways to help patients recover after hip replacement surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing first revision THR
• • Age ≥ 18 years
• • Motivated to participate in an exercise program for 16 weeks
• • Provided informed consent to participate
• • Patients who has the cup and/or stem replaced or a combination of liner and caput replaced
• • Patients who can be baseline tested (chair stand test, stair climb test, 40m walking test)
• Exclusion Criteria:
• • Dependency of wheelchair
• • Preplanned other lower limb surgery within 12 months
• • Body Mass Index (BMI) score \> 40
• • Currently undergoing cancer treatment, e.g. chemo-, immuno-, or radiotherapy.
• • Comorbidities that prevent exercise
• • Inadequacy in written and spoken Danish
• • Mentally unable to participate

Trial Officials